Semax and Selank TikTok reviews: what the research actually supports

A recent TikTok from creator Bethany Joy describes a one-week experience with the peptide pair Semax and Selank, calling them a potential “game changer” for cognitive focus and mood. The video, aimed at followers curious about nootropic peptides, implies that noticeable benefits can appear within days. But how much of that aligns with the published research?

What the clip claims

The clip presents Semax and Selank as fast-acting cognitive enhancers, with the creator sharing subjective impressions after just seven days. The caption hints at improved mental clarity and a possible shift in anxiety levels, though specific metrics are absent. The tone is enthusiastic, which is common in social media peptide reviews, but it risks conflating anecdotal experience with established efficacy.

What the research neighborhood actually covers

Semax (a synthetic ACTH(4-10) analog) and Selank (a synthetic tuftsin analog) have been studied primarily in Russian-speaking countries, with a focus on cognitive and anxiolytic effects. Preclinical studies suggest Semax may influence brain-derived neurotrophic factor (BDNF) and dopamine systems, while Selank appears to modulate GABAergic and serotonergic pathways. However, human data are limited to small trials, often with short durations, and many are not replicated in Western peer-reviewed journals. A 2018 review noted potential benefits in attention and memory, but called for larger, standardized trials.

Limits of the evidence

No robust clinical trial supports the claim that Semax or Selank produces noticeable cognitive changes within one week. Most studies use longer protocols, and outcomes are measured with neuropsychological tests, not subjective self-reports. Additionally, the peptides are typically administered intranasally, and bioavailability can vary. The TikTok review lacks controls, baseline measures, and blinding, making it impossible to separate placebo effects from genuine pharmacological action.

Research-use caveat

For researchers, Semax and Selank are interesting investigational tools, but they are not approved by the FDA for any cognitive or anxiety indication. In a research-use-only (RUO) context, they should be handled with strict protocols, and any human use outside approved studies is not supported. The peptides-pro catalog provides these compounds for laboratory investigation, not for self-experimentation.

Open the full video fact-check page (transcript, takeaways, embedded clip).